Integral Health Asset Management, LLC Gilead Sciences, Inc. Transaction History
Integral Health Asset Management, LLC
- $859 Million
- Q1 2025
A detailed history of Integral Health Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 175,000 shares of GILD stock, worth $19.8 Million. This represents 2.28% of its overall portfolio holdings.
Number of Shares
175,000
Previous 200,000
12.5%
Holding current value
$19.8 Million
Previous $18.5 Million
6.14%
% of portfolio
2.28%
Previous 1.65%
Shares
3 transactions
Others Institutions Holding GILD
# of Institutions
2,296Shares Held
999MCall Options Held
9.6MPut Options Held
10.1M-
Black Rock Inc. New York, NY121MShares$13.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.3 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.73 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.17 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.05 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $142B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...